Short stories

Halliburton company raises $10M, gBETA opens apps, Houston coworking space expands, and more innovation news

SheSpace announces its expansion — and more Houston innovation news you may have missed. Photo courtesy of SheSpace

It's been a busy summer for the Houston innovation ecosystem, and for this reason, local startup and tech news may have fallen through some of the cracks.

In this roundup of short stories within Houston innovation, a Halliburton Labs member company raises a series A, SheSpace is growing, gBETA is looking for its next cohort, and more.

Halliburton company raises $10 million

Halliburton Labs opens next round of applications

A Halliburton Labs company has raised fresh funding. Photo courtesy of Halliburton

Enexor Energy, one of Houston-based Halliburton Labs' participant companies, secured a $10 million investment from BorgWarner. The energy transition startup provides on-site, renewable energy, and carbon conversion solutions to help solve the world's organic waste and plastic waste problems.

"At Enexor, we all share a mutual passion for technological innovation and leaving a lasting legacy that betters humanity for generations long after we are gone," says Lee Jestings, founder and CEO of Enexor BioEnergy, in a news release. "We are thrilled to have a company like BorgWarner, that shares the same passion and is driven by a similar mission, invest so heavily in our company. I imagine this partnership will be fruitful for both of our companies and, more importantly, the world."

Enexor joined Halliburton Labs in February.

SheSpace announces expansion

For women by women: New coworking space to open in Houston

SheSpace is expanding its coworking spot. Image via shespacehtx.com

SheSpace is adding 1,500 square feet for a total of 7,500 square feet in the same spot it opened in November of last year (2799 Katy Freeway). The expansion will add supplementary event areas and 13 single and duo offices to its existing facilities, which includes 12 private offices, two event spaces, conference rooms, a fitness space, and a podcast studio.

"When our members succeed, we succeed," says founder Stephanie Tsuru, in a news release. "SheSpace grows because our members are growing and expanding in their respective businesses, and our expansion is a win for not only our members but all females."

According to the release, SheSpace's current facilities are at 100 percent capacity.

gBETA opens latest cohort applications

Early-stage startup accelerator names latest Houston cohort

Apps are open for gBETA. Photo courtesy of gBETA

Applications are open for gBETA's latest cohort. The early-stage program, which is a part of the nationally ranked startup accelerator gener8tor, is a free, seven-week accelerator for companies with local roots. Each program is capped at five teams, and requires no fees and no equity.

The deadline to apply is September 17, and the program will run from October 18 to December 17. Here is a direct link to view the application and apply.

Houston company joins Austin-based accelerator

Lodgeur

Lodgeur was accepted into Sputnik ATX. Photo courtesy of Lodguer

Houston-based Lodgeur has been selected for Austin-based accelerator Sputnik's summer 2021 cohort. Only five companies comprise the cohort — paired down from over 750 applications.

Lodgeur, co-founded by Brooke Bornick and Sebastien Long, allows apartment owners a chance to maximize rental income by providing turnkey flexible living service. Earlier this year, the company was named a MassChallenge - Houston finalist, as well as a semi-finalist in the Venture Houston 2021 Pitch Competition.

The five companies will go through three months of training and $100,000 in seed funding.

"What sets our program apart is the amount and caliber of mentoring our companies receive," says Dr. Oksana Malysheva, CEO and managing partner of Sputnik ATX, in a news release. "Sputnik ATX invests in the future; putting financial resources to work, training and advising founders who are skating to where the puck will be and helping them reach their full potential. Our newest cohort will change the food we eat, modernize how we find a place to live, expand a new type of lodging, help returning citizens maintain access to critical health care, and provide everyone the opportunity to be their best emotional and physical self."

SBA doles out $130 million in grants

moneyHouston ranks No. 3 on list of cities with the most people in financial distress amid COVID-19

SBA is doling out millions to hard-hit businesses. Photo via Getty Images

Earlier this month, the U.S. Small Business Administration awarded over $7.5 billion in Shuttered Venue Operators Grants (SVOG) to more than 10,000 small businesses, nonprofits, and venues. In Houston alone, over 120 businesses received more than $130 million in grant funding.

"Houston is one of only a few U.S. cities with permanent professional opera, ballet, music, and theater organizations— all considered world-class— as well as many highly rated museums, cinemas and entertainment venues," says district director, Tim Jeffcoat. "Through SBA's SVOG program, we have supplied important lifeline funding to organizations from all of these performing arts categories to rapidly restore operations and bring top-level entertainment back to Houston."

Trending News

Building Houston

 
 

The Texas Medical Center Innovation Factory has named the 16 companies making up the inaugural cohort in the Innovate UK Global Incubator Programme. Photo via tmc.edu

Sixteen digital health and medical device startups founded in the United Kingdom have been selected for a customized accelerator at the Texas Medical Center's Innovation Factory.

In partnership with Innovate UK, TMCi created the Innovate UK Global Incubator Programme, a new accelerator that supports UK businesses as they build their United States go-to-market plan. The program builds the BioBridge relationship between TMC and the UK that was originally established five years ago.

“The TMC UK BioBridge program was launched with the UK Department for Business and Trade in 2018 to serve as a gateway for advancing life sciences and foster innovation and research between our two countries," says Ashley McPhail, chief external affairs and administration officer for TMC, in a news release. "We saw an opportunity to work with Innovate UK to develop a larger program with the UK after the success of the 11 companies that previously participated in our health tech accelerator."

The 16 companies will participate in the program from June to November. The cohort is expected to arrive in Houston on June 5 and have access to TMCi's facilities, network of mentors and potential clients, funding, potential customers, and curated programing — all while being a unique entry point into the US. The new offering joins three other globally recognized curriculums: Biodesign, Accelerator for Cancer Therapeutics, and Health Tech.

“TMCi nurtures long-term growth, development, and competitiveness to increase startups chances of success and global expansion," says Emily Reiser, associate director of TMC Innovation. "By bringing their novel technologies and exposing them to a curated selection of TMC’s expert network, startups receive support and evaluation to build, scale, and expand in the US market."

Two of the cohort's specialties include cardiovascular and oncology — two of TMC's strongest areas of expertise — with solutions ranging from surgical devices to AI-enabled risk stratification and hospital efficiency.

Innovate UK is the country's national innovation agency dedicated to supporting business-led innovation in all sectors.

“The United Kingdom is fully committed to improving global healthcare through scientific collaboration," says His Majesty’s Consul General in Texas Richard Hyde in the release. "Through the expansion of the TMC UK BioBridge and in partnership with Innovate UK, this programme will help to expose the brightest and best British companies to the world’s largest medical city. Our companies will collaborate and grow as they work to develop cutting edge technology. The partnership between the UK Government and TMC demonstrates that international collaboration can drive both economic growth and improvement to quality of life.”

The 16 companies making up the inaugural cohort are as follows, according to TMC.

  • AINOSTICS aims to revolutionize the treatment and prevention of neurological conditions, such as dementia, by developing innovative AI-enabled solutions that draw novel insights from routinely acquired non-invasive medical scans to deliver accurate diagnosis and outcome prediction, and in turn facilitate personalized care and timely access to disease-modifying treatments for patients.
  • Alvie is a blended human plus AI-enabled digital solution providing personalised pre and rehabilitation coaching and supportive care for cancer and surgery. Alvie's technology combines data profiling, risk-stratification and tailored prescriptions of health and well-being with curated educational content, targeted behaviour change coaching and expert support through chat messaging and virtual consultations.
  • C the Signs™ is a validated AI cancer prediction platform, which can identify patients at risk of cancer at the earliest and most curable stage of the disease. Used by healthcare professionals, C the Signs can identify which tumor type a patient is at risk of and recommend the most appropriate next step in less than 30 seconds. The platform has detected over 10,000 patients with cancer, with over 50 different types of cancer diagnosed, and with a sensitivity of >98% for cancer.
  • At PEP Health, We believe all patients deserve the best care possible. Our cutting-edge machine-learning technology enables healthcare organisations, regulators, and insurers the real-time, actionable insights they need to have a direct and dramatic impact on patient experiences.
  • PreciousMD improves the lives of lung-cancer and other lung-related illnesses patients worldwide by enabling imaging-based diagnostics needed for personalized treatment pathways.
  • Ufonia is an autonomous telemedicine company, we use large language models and voice AI to increase the capacity of clinical professionals.
  • My mhealth offers digital therapeutics for a range of long-term conditions- COPD, Asthma, Diabetes and Heart Disease. Our product has been successfully deployed in the UK and India, with >100,000 users registered to date. Our solutions empower patients to self-manage their conditions, resulting in dramatic improvements in outcomes, as evidenced through multiple clinical trials and real-world evaluations.
  • At Surgery Hero, we offer a clinically backed solution that ensures whole-human support before and after surgery. We help health systems, employers and health plans cut costs without sacrificing quality of care.
  • Panakeia's software platform enables extremely rapid multi-omics profiling in minutes directly from routinely used tissue images without needing wet lab assays.
  • QV Bioelectronics are striving to deliver longer, better quality lives for brain tumour patients. Using their first-of-its-kind implantable electric field therapy device, GRACE, QV will provide effective, focal & continuous treatment without impacting patient quality of life.
  • 52 North is a med-tech company focused on improving health outcomes and health equity by reinventing care pathways. The NeutroCheck® solution is a finger-prick blood test and digital platform built to significantly improve safety and quality of life for cancer patients, by helping to identify at-home those patients who are at risk of the most fatal side-effect of chemotherapy: neutropenic sepsis.
  • Somnus is fulfilling an unmet need in global healthcare by developing real-time, point of care blood propofol monitoring. Its products will improve the care of sedated and anaesthetised patients, save money for hospitals, and facilitate a major reduction in greenhouse gas emissions.
  • ScubaTx is a breakthrough organ transplant preservation company established to solve the global unmet need for cost-efficient and longer-duration organ preservation technology. ScubaTx has developed a simple, small and affordable device which uses Persufflation to extend the preservation of organs.
  • IBEX is on a mission to help people live active, healthy and productive lives by increasing their access to early diagnosis of osteoporosis. The IBEX BH software as medical device delvers routine, automated assessment of fracture risk from routine radiology for earlier detection and more equitable treatment of osteoporosis.
  • NuVision produces products derived from donated human amniotic membrane that are used in ophthalmology to help patients with chronic, traumatic and post-surgical wounds of the eye to be treated earlier and recover more fully and more quickly. The company’s products are also used in the management of dry eye disease, a debilitating conditions that affects around 17m people in the USA.
  • Calon Cardio-Technology is on a mission to improve quality of life for patients with Left Ventricular Assist devices (LVAD) and reduce the common post operative complications associated with these implantable heart pumps. We plan to do this by introducing a completely wireless heart pump system and augment patient follow-up with built-in remote monitoring capabilities.

Trending News